In a Servier-sponsored satellite meeting at the Latest Advances in Psychiatry Symposium in London in March, Professor Bill Deakin, Professor of Psychiatry and Director of the Neuroscience and Psychiatry Unit at the University of Manchester, reviewed a recent addition to the antidepressant armamentarium - agomelatine - a drug that that shows a unique pharmacological profile. Medical writer, Mark Greener, reports. Copyright © 2009 Wiley Interface Ltd